subscribeSubscribe
price-trendAsk Us
Gossamer Bio to Host Webcast to Discuss Seralutinib Open-Label Extension Data

Gossamer Bio to Host Webcast to Discuss Seralutinib Open-Label Extension Data
BUSINESSWIRE
13 Dec 2023
Share Share
Gossamer Announces Seralutinib Meets Endpoint in PII TORREY Study in PAH

Gossamer Announces Seralutinib Meets Endpoint in PII TORREY Study in PAH
BUSINESSWIRE
06 Dec 2022
Share Share
Gossamer touts phase 2 win but investors are wary

Gossamer touts phase 2 win but investors are wary
Max Bayer FIERCEBIOTECH
06 Dec 2022
Share Share
Gossamer Bio Announces Second Quarter 2022 Financial Results

Gossamer Bio Announces Second Quarter 2022 Financial Results
BUSINESSWIRE
09 Aug 2022
Share Share